We are excited to announce the collaboration between Altoida and Hospital Clínic Barcelona on a groundbreaking study exploring plasma and digital biomarkers for the early detection of Alzheimer’s disease in primary care.
This innovative pilot study aims to recruit 400 participants over the next 18 months, combining blood tests with Altoida’s cognitive assessments to improve diagnostic accuracy and streamline patient care. As Marc Jones, CEO of Altoida, remarked, “This pilot project will provide invaluable insights and is just the beginning.”
Congratulations to both teams! Research and innovation are essential to the future of cognitive healthcare!
Read the press release
FOLLOW ALPANA NEWS:
Tour de l’Ile 1
CH – 1204 Geneva
+41 22 312 20 50
Energypolis
Rue de l’Industrie 23
1950 Sion
Copyright 2025 by ALPANA VENTURES – Disclaimer
Cookie | Durée | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |